Home › Triple-Negative Breast Cancer › Maryland › Germantown
Triple-Negative Breast Cancer clinical trials in Germantown, MD
4 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Germantown (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
RecruitingPhase 3
- MedStar Montgomery Medical Center ( Site 0078), Olney · 11 mi away
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
RecruitingPhase 3
- James M Stockman Cancer Institute, Frederick · 18 mi away
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- USOR Maryland Oncology Hematology, Rockville · 9 mi away
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
RecruitingObservational study
- Frederick Health Hospital, Frederick · 18 mi away
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO21 studies
- Arlington, VA20 studies
- Atlanta, GA20 studies
- Dallas, TX18 studies
- Chicago, IL16 studies
- Columbus, OH16 studies
Other studies in Germantown
- Non-Small Cell Lung Cancer17 studies
- Schizophrenia11 studies
- Breast Cancer10 studies
- Lung Cancer9 studies
- Cancer (all types)7 studies
- Depression7 studies
- Obesity7 studies
- Type 2 Diabetes7 studies
- Cardiovascular Disease6 studies
- Bladder Cancer6 studies
- Overweight5 studies
- Major Depressive Disorder5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.